|About DHS||Aging||Partners & Providers||Children||Disabilities||Economic Supports||Health Care||Publications||Licensing|
AIDS Drug Assistance Program (ADAP)
What is ADAP?
The AIDS Drug Assistance Program (ADAP) provides HIV/AIDS related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS.
ADAP funds are used to provide medications to treat HIV disease, or to prevent the serious deterioration of health, including measures for the prevention and treatment of opportunistic infections. As a payer of last resort, ADAP only serves individuals who have neither public nor private insurance or cannot get all of their medication needs met through their insurance payer.
In Minnesota, ADAP funds are used to both purchase drugs and to purchase cost-effective insurance.
How is ADAP funded?
AIDS Drug Assistance Programs (ADAPs) are authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act of 1990 (reauthorized in 1996 and 2000). ADAPs are not entitlement programs but are dependent on federal and state discretionary funding, which determines how many clients ADAPs can serve and what levels of service states can provide.
Minnesota also utilizes drug rebate dollars to supplement the ADAP budget as a method of cost containment.
Who is enrolled in ADAP in Minnesota?
To receive ADAP in Minnesota clients must meet the following eligibility guidelines:
What is the ADAP Drug Formulary?
The ADAP Drug Formulary is the list of medications ADAP pays for. Minnesota’s formulary includes all primary HIV treatment drugs, Opportunistic Infection (OI) drugs and a number of side effect drugs. Minnesota’s ADAP Drug Formulary has an advisory committee of HIV specialty physicians, pharmacists, case managers and consumers, who meet bi-annually to discuss issues and make recommendations.
Contact us with questions or feedback:
Twin Cities Metro area: (651) 431-2414 (voice) or (651) 431-7414 (fax)
Report/Rate this page
|© 2014 Minnesota Department of Human Services Online||Updated: 4/10/14 11:39 AM | Accessibility | Terms/Policy | Contact DHS | Top of Page ||